Terzah M. Horton, MD, PhD
- Cancer and Blood Disorders
Associate Professor, Department of Pediatrics, Section of Hematology-Oncology, Baylor College of Medicine
Hyundai Pediatric Cancer Research Scholar
Office location:
1102 Bates Avenue
Houston, TX 77030
Get to know Terzah M. Horton, MD, PhD
Dr. Terzah Horton is a graduate of Emory University where she received her Doctor of Medicine (M.D.) from the Emory University School of Medicine, as well as her Ph.D. She also attended her fellowship in pediatric hematology/oncology at Emory University and Baylor College of Medicine where she later became a faculty member in the Developmental Therapeutics Program at Texas Children's Hospital, the pediatric teaching hospital of Baylor College of Medicine. Dr. Horton is a board-certified member of the American Board of Pediatrics and is a board-certified specialist in pediatric Hematology Oncology.
Clinical Interests
Dr. Horton's clinical interests in oncology include developmental therapeutics.
Education
School | Education | Degree | Year |
---|---|---|---|
Baylor College of Medicine | Fellowship | Pediatric Hematology Oncology | 2002 |
Baylor College of Medicine | Residency | Pediatrics | 1999 |
Emory University School of Medicine | Medical School | Doctor of Medicine | 1996 |
Organizations
Organization Name | Role |
---|---|
American Academy of Pediatrics (AAP) | Member |
American Association of Cancer Research (AACR) | Member |
American Society for Clinical Oncology (ASCO) | Member |
American Society for Pediatric Hematology-Oncology (ASPHO) | Member |
Children's Oncology Group (COG) | Member |
Board Certifications
American Board of Pediatrics
American Board of Pediatrics - Pediatric Hematology/Oncology
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Research interests
Molecular causes of leukemia and lymphoma, Proteomics and the deregulation of cell cycle protein degradation during the development of malignancy, Developmental Therapeutics